Journal profile · Medicine-Radiology, Nuclear Medicine and Imaging
Clinical and Translational Radiation Oncology
ISSN 2405-6308 · Elsevier · Netherlands
Clinical and Translational Radiation Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.57; fully open access; APC about USD 2,530; median 80 days to acceptance (105 articles, last 24 months); 192 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical and Translational Radiation Oncology is published by Elsevier and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment and Head and Neck Cancer Studies, together about 32.4% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
An Official Journal of The European Society for Radiotherapy and OncologyClinical and Translational Radiation Oncology is an international, open access journal which encompasses all aspects of clinical and translational radiation oncology research, particularly new developments in experimental radiobiology, clinical interventions and treatments. This includes imaging and biomarker studies with clinical endpoints, as well as research results from data sciences, epidemiology, and oncopolicy.The journal publishes original research articles, review articles, short communications, technical notes, case series and reports, and correspondence.For any information regarding Clinical and Translational Radiation Oncology please contact ctro@elsevier.com.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Radiology, Nuclear Medicine and Imaging
Editor-in-chief Cihan GaniPublisher website
Editorial board by country: 2 in mainland China (about 5%); most named Germany 7, Italy 5, Canada 5, United Kingdom 3, France 3 (40 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Radiotherapy TechniquesPhysics and Astronomy17.4%
- Prostate Cancer Diagnosis and TreatmentMedicine8%
- Head and Neck Cancer StudiesMedicine7%
- Radiation Therapy and DosimetryMedicine5.6%
- Effects of Radiation ExposureMedicine5.3%
- Prostate Cancer Treatment and ResearchMedicine4.7%
- Lung Cancer Diagnosis and TreatmentMedicine4.5%
- Brain Metastases and TreatmentMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.57LetPub ·
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 5.7LetPub ·
- CiteScore (publisher)
- 5.7Publisher website ·
- SJR 2026-06
- 1.25LetPub ·
- SNIP 2026-06
- 1.19LetPub ·
- h-index
- 48OpenAlex ·
- i10-index
- 396OpenAlex ·
- 2-year mean citedness
- 1.95OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 99.79%LetPub ·
Volume
- Articles per year
- 171LetPub ·
Articles by year OpenAlex count · 1,284 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 191 | 191 | 14 |
| 2025 | 192 | 192 | 229 |
| 2024 | 186 | 186 | 867 |
| 2023 | 143 | 143 | 1,046 |
| 2022 | 138 | 138 | 1,567 |
| 2021 | 110 | 110 | 1,509 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
80 daysMedian, submission to acceptance · P25–P75 56 days – 106 days
- Acceptance to online
- median 2 days (105 articles)
- Submission to online
- median 86 days
- Sample
- 105 articles with submission and acceptance dates (438 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 28 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 37 daysPublisher website ·
- Submission to acceptance
- 74 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,530 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,430 / EUR 2,270 / GBP 1,950 / JPY 301,390 | — | — | |
| LetPub | EUR 1,720 | Yes | — | |
| Publisher website | USD 2,530 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted17, with length limits
- case report1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…main text ≤ 1,500 words
- case reports and case series5. Case reports and case seriesLength not stated
- correspondence6. CorrespondenceLength not stated
- editorial1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- full paper1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- guidelines / delphi consensus recommendations4. Guidelines / Delphi Consensus Recommendations (5000 words max. excluding the reference list; note: for exceptional surveys only, aim for 3000 words)Length not stated
- original research article1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- original research articles1. Original research articles (max. 3000 words)Length not stated
- protocol1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- protocols7. Protocols (max. 3000 words)Length not stated
- review1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- review article1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- review articles3. Review articles (max. 5000 words)Length not stated
- short communication1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
- short communications and technical notes2. Short communications and technical notes (max. 2000 words)Length not stated
- survey1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…main text ≤ 3,000 words
- technical note1. Original research articles (max. 3000 words)Describe original scientific work in the field of radiation oncology or related areas. The content of the paper s…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Publishing ethics policy Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2405-6308
- Society / sponsor
- European Society for Radiotherapy and Oncology
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical and Translational Radiation Oncology
What CAS zone is Clinical and Translational Radiation Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Translational Radiation Oncology is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology / Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Translational Radiation Oncology?
The latest impact factor listed by LetPub is 3.57; CiteScore 5.7, h-index 48.
How long does peer review take at Clinical and Translational Radiation Oncology?
Based on the dates recorded on 105 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 80 days (interquartile range 56–106 days); authors report an average review time of about 28 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical and Translational Radiation Oncology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical and Translational Radiation Oncology based?
Of the 40 board members whose country the journal's board page names, 2 (about 5%) are in mainland China; the countries named most often are Germany (7), Italy (5) and Canada (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Translational Radiation Oncology?
According to LetPub and DOAJ records, Clinical and Translational Radiation Oncology is indexed in SCIE, Scopus and DOAJ.
Is Clinical and Translational Radiation Oncology open access, and what is the APC?
Clinical and Translational Radiation Oncology is a fully open-access journal. APC about USD 2,530.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .